New antiseptic gel put to the test against surgical germs
NCT ID NCT00636480
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a new chlorhexidine-based skin cleanser can kill bacteria on the skin as well as an already-approved product. Sixty healthy adults had the new cleanser, the approved product, or a placebo applied to their skin before surgery. Researchers measured how many bacteria remained to see if the new product meets FDA standards for preventing infections.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Chlorhexidine gluconate (2% w/v) with or without isopropyl alcohol, applied topically to the skin
- What this could lead to
- If successful, this could confirm that the new skin-cleansing product is as effective as an already-approved one at reducing bacteria before surgery, helping prevent surgical infections.
- What could go wrong
- This is a small, early-phase study (60 people) testing only short-term germ reduction on the skin, not actual infection rates. Results may not translate to real-world surgical outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TOPICAL ANTISEPSIS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
BioScience Laboratories
Bozeman, Montana, 59715, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.